Intellipharmaceutics International Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q2 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Intellipharmaceutics International Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q2 2017 to Q3 2023.
  • Intellipharmaceutics International Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending August 31, 2023 was $0.000.
  • Intellipharmaceutics International Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $0.000.
  • Intellipharmaceutics International Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $0.000.
  • Intellipharmaceutics International Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $0.000, a 100% decline from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Trailing 12 Months (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 Jun 1, 2023 Aug 31, 2023 6-K 2023-10-16
Q3 2022 $0 Jun 1, 2022 Aug 31, 2022 6-K 2023-10-16
Q4 2020 $0 $0 -$2.23K -100% Sep 1, 2020 Nov 30, 2020 20-F/A 2024-02-06
Q3 2020 $2.23K $0 -$29.4K -100% Jun 1, 2020 Aug 31, 2020 6-K 2020-10-15
Q2 2020 $31.6K $0 -$44.3K -100% Mar 1, 2020 May 31, 2020 6-K 2020-07-15
Q1 2020 $76K $0 -$63.8K -100% Dec 1, 2019 Feb 29, 2020 6-K 2020-05-29
Q4 2019 $140K $2.23K -$113K -98.1% Sep 1, 2019 Nov 30, 2019 20-F 2021-03-31
Q3 2019 $253K $29.4K +$17K +137% Jun 1, 2019 Aug 31, 2019 6-K 2020-10-15
Q2 2019 $236K $44.3K +$30.6K +222% Mar 1, 2019 May 31, 2019 6-K 2020-07-15
Q1 2019 $206K $63.8K -$4.02K -5.93% Dec 1, 2018 Feb 28, 2019 6-K 2020-05-29
Q4 2018 $210K $116K Sep 1, 2018 Nov 30, 2018 20-F 2021-03-31
Q3 2018 $12.4K +$12.4K Jun 1, 2018 Aug 31, 2018 6-K 2019-10-11
Q2 2018 $13.8K -$38.6K -73.7% Mar 1, 2018 May 31, 2018 6-K 2019-07-10
Q1 2018 $67.9K Dec 1, 2017 Feb 28, 2018 6-K 2019-04-15
Q3 2017 $0 Jun 1, 2017 Aug 31, 2017 6-K 2018-10-15
Q2 2017 $52.3K Mar 1, 2017 May 31, 2017 6-K/A 2018-07-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.